• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.07% Nasdaq Up 0.32%

    OncoMed Pharmaceuticals, Inc. (OMED)

    -NasdaqGS
    20.34 Up 0.66(3.35%) Aug 28, 4:00PM EDT
    Add to Portfolio
    Prev Close:19.68
    Open:19.46
    Bid:N/A
    Ask:29.99 x 2000
    1y Target Est:39.25
    Beta:2.06729
    Earnings Date:Nov 2 - Nov 6 (Est.)
    Day's Range:19.44 - 20.41
    52wk Range:16.63 - 29.83
    Volume:116,731
    Avg Vol (3m):134,546
    Market Cap:611.46M
    P/E (ttm):N/A
    EPS (ttm):-1.90
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for OMED

    Comparison

    Symbol% ChgMkt Cap
    OMEDUp 3.35%611.46M
    STMLUp 5.26%172.73M
    VSTMUp 7.14%221.38M

    Key Statistics

    Forward P/E (1 yr):29.48
    P/S (ttm):14.12
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.84
    Quarterly EPS Est (Sep-15) :-0.62
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    OncoMed Pharmaceuticals, Inc., a clinical development-stage biotechnology company, discovers and develops protein therapeutics targeting cancer stem cells (CSCs). View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback